PAPER Majounie E, Abramzon Y, Renton AE, Keller MF, Traynor BJ, Singleton AB
SEARCH RESULTS
329939 RESULTS
PAPER Roy A, Ghosh A, Jana A, Liu X, Brahmachari S, Gendelman HE, Pahan K
Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's disease.
PLoS One. 2012;7(6):e38113. Epub 2012 Jun 18 PubMed: 22723850PAPER Albin RL, Dauer WT
Parkinson syndrome: Heterogeneity of etiology; heterogeneity of pathogenesis?
Neurology. 2012 Jun 20; PubMed: 22722622PAPER Sasayama H, Shimamura M, Tokuda T, Azuma Y, Yoshida T, Mizuno T, Nakagawa M, Fujikake N, Nagai Y, Yamaguchi M
Knockdown of the Drosophila fused in sarcoma (FUS) homologue causes deficient locomotive behavior and shortening of motoneuron terminal branches.
PLoS One. 2012;7(6):e39483. PubMed: 22724023PAPER Duennwald ML, Echeverria A, Shorter J
Small heat shock proteins potentiate amyloid dissolution by protein disaggregases from yeast and humans.
PLoS Biol. 2012 Jun;10(6):e1001346. PubMed: 22723742PAPER Noorian AR, Rha J, Annerino DM, Bernhard D, Taylor GM, Greene JG
Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system.
Neurobiol Dis. 2012 Oct;48(1):9-19. PubMed: 22722052PAPER Brockmann K, Hilker R, Pilatus U, Baudrexel S, Srulijes K, Magerkurth J, Hauser AK, Schulte C, Csoti I, Merten CD, Gasser T, Berg D, Hattingen E
GBA-associated PD. Neurodegeneration, altered membrane metabolism, and lack of energy failure.
Neurology. 2012 Jul 17;79(3):213-20. PubMed: 22722629PAPER Petroi D, Popova B, Taheri-Talesh N, Irniger S, Shahpasandzadeh H, Zweckstetter M, Outeiro TF, Braus GH
Aggregate Clearance of α-Synuclein in Saccharomyces cerevisiae Depends More on Autophagosome and Vacuole Function Than on the Proteasome.
J Biol Chem. 2012 Aug 10;287(33):27567-79. PubMed: 22722939PAPER Yang J, Wang X, Wang Y, Guo ZX, Luo DZ, Jia J, Wang XM
Dopaminergic neuronal conversion from adult rat skeletal muscle-derived stem cells in vitro.
Neurochem Res. 2012 Sep;37(9):1982-92. PubMed: 22723079PAPER Orr ME, Pitstick R, Canine B, Ashe KH, Carlson GA
Genotype-specific differences between mouse CNS stem cell lines expressing frontotemporal dementia mutant or wild type human tau.
PLoS One. 2012;7(6):e39328. PubMed: 22723997PAPER Masliah E, Díez-Tejedor E
The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders.
Drugs Today (Barc). 2012 Apr;48 Suppl A:3-24. PubMed: 22514792PAPER Auer S, Ricchiuto P, Kashchiev D
Two-step nucleation of amyloid fibrils: omnipresent or not?
J Mol Biol. 2012 Oct 5;422(5):723-30. PubMed: 22721952PAPER Igoumenou A, Ebmeier KP
Diagnosing and managing vascular dementia.
Practitioner. 2012 Jan;256(1747):13-6, 2. PubMed: 22720454PAPER Allegri RF, Guekht A
Cerebrolysin improves symptoms and delays progression in patients with Alzheimer's disease and vascular dementia.
Drugs Today (Barc). 2012 Apr;48 Suppl A:25-41. PubMed: 22514793PAPER Piper BJ, Yasen AL, Taylor AE, Ruiz JR, Gaynor JW, Dayger CA, Gonzalez-Gross M, Kwon OD, Nilsson LG, Day IN, Raber J, Miller JK
Non-replication of an association of Apolipoprotein E2 with sinistrality.
Laterality. 2012 Jun 21; PubMed: 22721421Current Filters
No filters selected